The biology and treatment of EML4-ALK non-small cell lung cancer

被引：483
|
作者：
Sasaki, Takaaki [1 ,2 ]
Rodig, Scott J. [3 ]
Chirieac, Lucian R. [3 ]
Janne, Pasi A. [1 ,2 ,4 ,5 ]
机构：
[1] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2010年 / 46卷 / 10期
基金：
美国国家卫生研究院;
关键词：
Non-small cell lung carcinoma; Translocation; Kinase inhibitor; Clinical trial; GROWTH-FACTOR-RECEPTOR; CLINICOPATHOLOGICAL FEATURES; FUSION GENE; ANAPLASTIC LYMPHOMA; TUMOR-SUPPRESSOR; MUTATIONS; ALK; KINASE; KRAS; ADENOCARCINOMA;
D O I：
10.1016/j.ejca.2010.04.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The fusion between echinoderm microtubule-associated protein-like 4 (EML4) and anaplastic lymphoma kinase (ALK),has recently been identified in a subset of non-small cell lung cancers (NSCLCs). EML4-ALK is most often detected in never smokers with lung cancer and has unique pathologic features. EML4-ALK is oncogenic both in vitro and in vivo and ALK kinase inhibitors are quite effective in pre-clinical model systems. More recently ALK inhibitors have entered clinical development and remarkably clinical efficacy has been observed in NSCLC patients harbouring EML4-ALK translocations. This review will focus on the biology, clinical characteristics, diagnosis and treatment of EML4-ALK NSCLC. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1773 / 1780
页数：8
相关论文
共 50 条
  • [1] EML4-ALK fusion gene in non-small cell lung cancer
    Lei, Yu
    Lei, Yan
    Shi, Xiang
    Wang, Jingjing
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [2] The Biology and Clinical Features of Non-small Cell Lung Cancers with EML4-ALK Translocation
    Pillai, Rathi N.
    Ramalingam, Suresh S.
    CURRENT ONCOLOGY REPORTS, 2012, 14 (02) : 105 - 110
  • [3] EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer
    Jin, Guang
    Jeon, Hyo-Sung
    Lee, Eung Bae
    Kang, Hyo-Gyoung
    Yoo, Seung Soo
    Lee, Shin Yup
    Lee, Jae Hee
    Cha, Sung Ick
    Park, Tae In
    Kim, Chang Ho
    Jheon, Sang Hoon
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (02) : 228 - 230
  • [4] Analysis of EML4-ALK rearrangement in non-small cell lung cancer in Argentina
    Verzura, Maria
    Batagelj, Emilio
    Bagnes, Claudia
    Martin, Claudio
    Enrico, Diego
    Richardet, Eduardo
    De la Iglesia, Paola
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 : 77 - 81
  • [5] Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)
    Moran, Teresa
    Quiroga, Vanesa
    Llanos Gil, Maria de Los
    Vila, Laia
    Pardo, Nuria
    Carcereny, Enric
    Capdevila, Laia
    Munoz-Marmol, Ana M.
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (02) : 128 - 141
  • [6] EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer
    de Mello, Ramon Andrade
    Liu, Davi J. J.
    Aguiar, Pedro N., Jr.
    Tadokoro, Hakaru
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2016, 11 (04) : 393 - 400
  • [7] EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries
    Elshatlawy, Mariam
    Sampson, Josephina
    Clarke, Katy
    Bayliss, Richard
    MOLECULAR ONCOLOGY, 2023, 17 (06) : 950 - 963
  • [8] EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
    Martelli, Maria Paola
    Sozzi, Gabriella
    Hernandez, Luis
    Pettirossi, Valentina
    Navarro, Alba
    Conte, Davide
    Gasparini, Patrizia
    Perrone, Federica
    Modena, Piergiorgio
    Pastorino, Ugo
    Carbone, Antonino
    Fabbri, Alessandra
    Sidoni, Angelo
    Nakamura, Shigeo
    Gambacorta, Marcello
    Luis Fernandez, Pedro
    Ramirez, Jose
    Chan, John K. C.
    Grigioni, Walter Franco
    Campo, Elias
    Pileri, Stefano A.
    Falini, Brunangelo
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (02): : 661 - 670
  • [9] ANALYSIS OF EML4-ALK POSITIVE NON-SMALL CELL LUNG CANCER WITH ADVANCED STAGE
    Park, J.
    Kondo, C.
    Shimizu, J.
    Horio, Y.
    Yoshida, K.
    Yatabe, Y.
    Mitsudomi, T.
    Hida, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 433 - 434
  • [10] EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer Response
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (05) : 578 - 578
12345